Char Kicos
Psychiatric/Mental Health · Canton, OHNPI 1477195550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. 2023 is the largest year on record at $2,464, 2.3 times the $1,051 reported in 2021. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Axsome Therapeutics, Inc.$839
- AbbVie$716
- Teva Pharmaceuticals USA, Inc.$504
- Neurocrine Biosciences, Inc.$492
- Otsuka America Pharmaceutical, Inc.$475
- plus $1K from 9 others
What the payments were for
- Food & beverage$5,41297%
- Education$1593%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 58 | $1,152 |
| Axsome Therapeutics, Inc. | 38 | $839 |
| AbbVie | 37 | $716 |
| Teva Pharmaceuticals USA, Inc. | 28 | $504 |
| Neurocrine Biosciences, Inc. | 17 | $492 |
| Otsuka America Pharmaceutical, Inc. | 28 | $475 |
| Lundbeck LLC | 32 | $435 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $262 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $218 |
| Idorsia Pharmaceuticals US Inc | 10 | $201 |
| Johnson & Johnson | 10 | $163 |
| Vanda Pharmaceuticals Inc. | 3 | $48 |
| Almatica Pharma LLC | 2 | $27 |
| Validus Pharmaceuticals LLC | 1 | $25 |
| Neuronetics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$908
- ARISTADA$418
- INGREZZA$311
- VRAYLAR$214
- Auvelity$124
- QUVIVIQ$115
- ARISTADA INITIO$104
- CAPLYTA$101
- ABILIFY MAINTENA$100
How this compares
$5,571 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Canton
- David OnderCanton$28K
- Tara DavisCanton$14K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.